Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Howard, DM; Adams, MJ; Clarke, TK; Hafferty, JD; Gibson, J; Shirali, M; Coleman, JRI; Hagenaars, SP; Ward, J; Wigmore, EM; Alloza, C; Shen, X; Barbu, MC; Xu, EY; Whalley, HC; Marioni, RE; Porteous, DJ; Davies, G; Deary, IJ; Hemani, G; Berger, K; Teismann, H; Rawal, R; Arolt, V; Baune, BT; Dannlowski, U; Domschke, K; Tian, C; Hinds, DA; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Hicks, B; Huber, KE; Jewett, EM; Jiang, Y; Kleinman, A; Lin, KH; Litterman, NK; McIntyre, MH; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Poznik, GD; Sathirapongsasuti, JF; Sazonova, OV; Shelton, JF; Shringarpure, S; Tung, JY; Vacic, V; Wang, X; Wilson, CH; Trzaskowski, M; Byrne, EM; Ripke, S; Smith, DJ; Sullivan, PF; Wray, NR; Breen, G; Lewis, CM; McIntosh, AM; 23andMe Res Team; Major Depressive Disorder Working.

Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

NATURE NEUROSCIENCE. 2019; 22(3): 343 Nº de citas: 581 [doi:10.1038/s41593-018-0326-7]

Barbeito, S; Sanchez-Gutierrez, T; Mayoral, M; Moreno, M; Rios-Aguilar, S; Arango, C; Calvo, A.

Mobile App-Based Intervention for Adolescents With First-Episode Psychosis: Study Protocol for a Pilot Randomized Controlled Trial

Frontiers in Psychiatry. 2019; 10: Nº de citas: 12 [doi:10.3389/fpsyt.2019.00027]

Gialloreti, LE; Mazzone, L; Benvenuto, A; Fasano, A; Alcon, AG; Kraneveld, A; Moavero, R; Raz, R; Riccio, MP; Siracusano, M; Zachor, DA; Marini, M; Curatolo, P.

Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations

Journal of Clinical Medicine. 2019; 8(2): Nº de citas: 98 [doi:10.3390/jcm8020217]

Bilderbeck, AC; Penninx BWJH; Arango, C; van der Wee, N; Kahn, R; Winter-van Rossum, I; Hayen, A; Kas, MJ; Post, A; Dawson, GR.

Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 87-93 Nº de citas: 20 [doi:10.1016/j.neubiorev.2018.06.019]

Kas, MJ; Penninx, B; Sommer, B; Serretti, A; Arango, C; Marston, H.

A quantitative approach to neuropsychiatry: The why and the how

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 3-9 Nº de citas: 81 [doi:10.1016/j.neubiorev.2017.12.008]

van der Wee NJA; Bilderbeck, AC; Cabello, M; Ayuso-Mateos, JL; Saris IMJ; Giltay, EJ; Penninx, BWJH; Arango, C; Post, A; Porcelli, S.

Working definitions, subjective and objective assessments and experimental paradigms in a study exploring social withdrawal in schizophrenia and Alzheimer's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019; 97: 38-46 Nº de citas: 18 [doi:10.1016/j.neubiorev.2018.06.020]

Martinuzzi, E; Barbosa, S; Daoudlarian, D; Ali, WBH; Gilet, C; Fillatre, L; Khalfallah, O; Troudet, R; Jamain, S; Fond, G; Sommer, I; Leucht, S; Dazzan, P; McGuire, P; Arango, C; Diaz-Caneja, CM; Fleischhacker, W; Rujescu, D; Glenthoj, B; Winter, I; Kahn, RS; Yolken, R; Lewis, S; Drake, R; Davidovic, L; Leboyer, M; Glaichenhaus, N; Kahn, RS; van Rossum, IW; Leucht, S; McGuire, P; Lewis, SW; Leboyer, M; Arango, C; Dazzan, P; Drake, R; Heres, S; Diaz-Caneja, CM; Rujescu, D; Weiser, M; Galderisi, S; Glenthoj, B; Eijkemans, MJC; Fleischhacker, WW; Kapur, S; Sommer, IE; OPTiMiSE Study Grp.

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study

Translational Psychiatry. 2019; 9: Nº de citas: 59 [doi:10.1038/s41398-018-0366-5]

Jaen-Moreno, MJ; Feu, N; Redondo-Ecija, J; Montiel, FJ; Gomez, C; del Pozo, GI; Alcala, JA; Gutierrez-Rojas, L; Balanza-Martinez, V; Chauca, GM; Carrion, L; Osuna, MI; Sanchez, MD; Caro, I; Ayora, M; Valdivia, F; Lopez, MS; Poyato, JM; Sarramea, F.

Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk TIMER): study protocol for a randomized controlled trial

Trials. 2019; 20: Nº de citas: 4 [doi:10.1186/s13063-018-3139-9]

Gonzalez-Penas, J; Costas, J; Villamayor, MJG; Xu, B.

Enrichment of rare genetic variants in astrocyte gene enriched co-expression modules altered in postmortem brain samples of schizophrenia

NEUROBIOLOGY OF DISEASE. 2019; 121: 305-314 Nº de citas: 9 [doi:10.1016/j.nbd.2018.10.013]

Diaz-Caneja, CM; Cervilla, JA; Haro, JM; Arango, C; de Portugal, E.

Cognition and functionality in delusional disorder

EUROPEAN PSYCHIATRY. 2019; 55: 52-60 Nº de citas: 17 [doi:10.1016/j.eurpsy.2018.09.010]

Fraguas, D; Diaz-Caneja, CM; Pina-Camacho, L; Umbricht, D; Arango, C.

Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis

SCHIZOPHRENIA BULLETIN. 2019; 45(1): 57-68 Nº de citas: 19 [doi:10.1093/schbul/sbx192]

Downs, J; Dean, H; Lechler, S; Sears, N; Patel, R; Shetty, H; Hotopf, M; Ford, T; Kyriakopoulos, M; Diaz-Caneja, CM; Arango, C; MacCabe, JH; Hayes, RD; Pina-Camacho, L.

Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure

SCHIZOPHRENIA BULLETIN. 2019; 45(1): 69-79 Nº de citas: 44 [doi:10.1093/schbul/sbx197]

Boloc, D; Gortat, A; Cheng-Zhang, JQ; Garcia-Cerro, S; Rodriguez, N; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Gasso, P; Lafuente, A; Bernardo, M; Mas, S.

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

Translational Psychiatry. 2018; 8: 276-276 Nº de citas: 14 [doi:10.1038/s41398-018-0330-4]

Hoffmann, C; Stevens, J; Zong, SH; van Kruining, D; Saxena, A; Kucukali, CI; Tuzun, E; Yalcinkaya, N; De Hert, M; Gonzalez-Vioque, E; Arango, C; Lindstrom, J; De Beets, MH; Rutter, BPF; van Os, J; Molenaar, P; Losen, M; Martinez-Martinez, P.

Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder

PLoS One. 2018; 13(12): Nº de citas: 12 [doi:10.1371/journal.pone.0208412]

Garcia-Cabeza, I; Diaz-Caneja, CM; Ovejero, M; de Portugal, E.

Adherence, insight and disability in paranoid schizophrenia

PSYCHIATRY RESEARCH. 2018; 270: 274-280 Nº de citas: 10 [doi:10.1016/j.psychres.2018.09.021]

Miguelez-Fernandez, C; de Leon, SJ; Baltasar-Tello, I; Penuelas-Calvo, I; Barrigon, ML; Capdevila, AS; Delgado-Gomez, D; Baca-Garcia, E; Carballo, JJ.

Evaluating attention-deficit/hyperactivity disorder using ecological momentary assessment: a systematic review.

ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS. 2018; 10(4): 247-265 Nº de citas: 11 [doi:10.1007/s12402-018-0261-1]

Amoretti, S; Cabrera, B; Torrent, C; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Parellada, M; Corripio, I; Vieta, E; de la Serna, E; Butjosa, A; Contreras, F; Sarro, S; Penades, R; Sanchez-Torres, AM; Cuesta, M; Bernardo, M; PEPsGrp.

Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

ACTA PSYCHIATRICA SCANDINAVICA. 2018; 138(5): 441-455 Nº de citas: 67 [doi:10.1111/acps.12949]

Diaz-Caneja, CM; Moron-Nozaleda, MG; Vicente-Moreno, RP; Rodriguez-Toscano, E; Pina-Camacho, L; de la Serna, E; Sugranyes, G; Baeza, I; Romero, S; Sanchez-Gistau, V; Castro-Fornieles, J; Moreno, C; Moreno, D.

Temperament in child and adolescent offspring of patients with schizophrenia and bipolar disorder

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2018; 27(11): 1459-1471 Nº de citas: 11 [doi:10.1007/s00787-018-1135-y]